106910-81-0 Usage
Uses
Used in Pharmaceutical Industry:
4-BENZYL-5-OXO-MORPHOLINE-3-CARBOXYLIC ACID METHYL ESTER is used as a key intermediate in the synthesis of various medications, leveraging its unique chemical structure to contribute to the development of new drugs.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-BENZYL-5-OXO-MORPHOLINE-3-CARBOXYLIC ACID METHYL ESTER serves as a building block for the creation of novel compounds with potential therapeutic properties.
Used in the Development of Analgesic Drugs:
4-BENZYL-5-OXO-MORPHOLINE-3-CARBOXYLIC ACID METHYL ESTER is utilized as a precursor in the development of analgesic drugs, aiming to alleviate pain through its chemical interactions.
Used in the Development of Anti-inflammatory Drugs:
4-BENZYL-5-OXO-MORPHOLINE-3-CARBOXYLIC ACID METHYL ESTER is also employed in the creation of anti-inflammatory medications, potentially reducing inflammation and associated symptoms.
Used in the Development of Anticonvulsant Drugs:
4-BENZYL-5-OXO-MORPHOLINE-3-CARBOXYLIC ACID METHYL ESTER is used in the synthesis of anticonvulsant drugs, which are designed to prevent or reduce the severity of seizures.
Check Digit Verification of cas no
The CAS Registry Mumber 106910-81-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,9,1 and 0 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 106910-81:
(8*1)+(7*0)+(6*6)+(5*9)+(4*1)+(3*0)+(2*8)+(1*1)=110
110 % 10 = 0
So 106910-81-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H15NO4/c1-17-13(16)11-8-18-9-12(15)14(11)7-10-5-3-2-4-6-10/h2-6,11H,7-9H2,1H3
106910-81-0Relevant articles and documents
Chiral Synthesis of 3-Substituted Morpholines via Serine Enantiomers and Reductions of 5-Oxomorpholine-3-carboxylates
Brown, George R.,Foubister, Alan J.,Wright, Brian
, p. 2577 - 2580 (2007/10/02)
The chiral synthesis of 3-hydroxymethyl- and 3-carboxy-morpholines from serine enantiomers is described.Chemoselective and total reductions of 5-oxomorpholine-3-carboxylates are key synthetic steps.
